Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs

J. GREBELY ; S. LARNEY ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; M. HICKMAN ; P. VICKERMAN ; S. BLACH ; E. B. CUNNINGHAM ; K. DUMCHEV ; M. LYNSKEY ; J. STONE ; A. TRICKEY ; H. RAZAVI ; R. P. MATTICK ; M. FARRELL ; G. J. DORE ; L. DEGENHARDT | 2019
Dans Addiction (Vol.114, n°1, January 2019) Article : Périodique

BACKGROUND AND AIMS: People who have recently injected drugs are a priority population in efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the prevalence and number of people with recent injecting drug use living with[...]

Plus d'info

Ajouter à la sélection

Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis

L. PLATT ; P. EASTERBROOK ; E. GOWER ; B. MCDONALD ; K. SABIN ; C. McGOWAN ; I. YANNY ; H. RAZAVI ; P. VICKERMAN | 2016
Dans Lancet Infectious Diseases (The) (Vol.16, n°7, July 2016) Article : Périodique

Background: At global level, there are 37 million people infected with HIV and 115 million people with antibodies to hepatitis C virus (HCV). Little is known about the extent of HIV-HCV co-infection. We sought to characterise the epidemiology an[...]

Plus d'info

Ajouter à la sélection